US1088538A
(en)
*
|
1913-07-28 |
1914-02-24 |
Chester H Clark |
Grease-cup.
|
US2042369A
(en)
|
1935-04-23 |
1936-05-26 |
Kilian Albert Von |
One-button switch
|
US3691016A
(en)
|
1970-04-17 |
1972-09-12 |
Monsanto Co |
Process for the preparation of insoluble enzymes
|
CA1023287A
(en)
|
1972-12-08 |
1977-12-27 |
Boehringer Mannheim G.M.B.H. |
Process for the preparation of carrier-bound proteins
|
GB1479268A
(en)
|
1973-07-05 |
1977-07-13 |
Beecham Group Ltd |
Pharmaceutical compositions
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
GB1451798A
(en)
|
1973-08-02 |
1976-10-06 |
Ici Ltd |
Prostanoic acid derivatives
|
CH596313A5
(zh)
|
1975-05-30 |
1978-03-15 |
Battelle Memorial Institute |
|
US4385260A
(en)
*
|
1975-09-09 |
1983-05-24 |
Beckman Instruments, Inc. |
Bargraph display
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
IL63270A0
(en)
|
1980-08-05 |
1981-10-30 |
Univ Leland Stanford Junior |
Eukaryotic autonomously replicating segment
|
US4414147A
(en)
|
1981-04-17 |
1983-11-08 |
Massachusetts Institute Of Technology |
Methods of decreasing the hydrophobicity of fibroblast and other interferons
|
JPS57206622A
(en)
*
|
1981-06-10 |
1982-12-18 |
Ajinomoto Co Inc |
Blood substitute
|
US4579821A
(en)
|
1981-11-23 |
1986-04-01 |
University Patents, Inc. |
Control of DNA sequence transcription
|
US4656134A
(en)
|
1982-01-11 |
1987-04-07 |
Board Of Trustees Of Leland Stanford Jr. University |
Gene amplification in eukaryotic cells
|
US4975276A
(en)
|
1982-01-15 |
1990-12-04 |
Cetus Corporation |
Interferon-alpha 54
|
US4695543A
(en)
|
1982-03-23 |
1987-09-22 |
Bristol-Myers Company |
Alpha Interferon GX-1
|
US4748233A
(en)
|
1982-03-23 |
1988-05-31 |
Bristol-Myers Company |
Alpha-interferon Gx-1
|
US6936694B1
(en)
|
1982-05-06 |
2005-08-30 |
Intermune, Inc. |
Manufacture and expression of large structural genes
|
HU204097B
(en)
|
1982-05-19 |
1991-11-28 |
Gist Brocades Nv |
Process for producing cloning system relating to kluyveromyces species
|
US4486533A
(en)
|
1982-09-02 |
1984-12-04 |
St. Louis University |
Filamentous fungi functional replicating extrachromosomal element
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4599311A
(en)
|
1982-08-13 |
1986-07-08 |
Kawasaki Glenn H |
Glycolytic promotersfor regulated protein expression: protease inhibitor
|
US5151511A
(en)
|
1982-09-16 |
1992-09-29 |
Amgen Inc. |
DNA encoding avian growth hormones
|
US4737462A
(en)
|
1982-10-19 |
1988-04-12 |
Cetus Corporation |
Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
US4966843A
(en)
|
1982-11-01 |
1990-10-30 |
Cetus Corporation |
Expression of interferon genes in Chinese hamster ovary cells
|
US4438253A
(en)
|
1982-11-12 |
1984-03-20 |
American Cyanamid Company |
Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
US4603044A
(en)
|
1983-01-06 |
1986-07-29 |
Technology Unlimited, Inc. |
Hepatocyte Directed Vesicle delivery system
|
US4713339A
(en)
|
1983-01-19 |
1987-12-15 |
Genentech, Inc. |
Polycistronic expression vector construction
|
DE3308806A1
(de)
|
1983-03-12 |
1984-09-13 |
Basf Ag, 6700 Ludwigshafen |
Fungizide mittel, substituierte glucopyranosylamine und verfahren zur bekaempfung von pilzen
|
JPS59172425A
(ja)
|
1983-03-18 |
1984-09-29 |
Nippon Chemiphar Co Ltd |
新規な血液凝固因子誘導体およびその製造法ならびにそれを含有する血液凝固促進剤
|
US4518584A
(en)
|
1983-04-15 |
1985-05-21 |
Cetus Corporation |
Human recombinant interleukin-2 muteins
|
US4745051A
(en)
|
1983-05-27 |
1988-05-17 |
The Texas A&M University System |
Method for producing a recombinant baculovirus expression vector
|
US4840896A
(en)
|
1983-11-02 |
1989-06-20 |
Integrated Genetics, Inc. |
Heteropolymeric protein
|
US4923805A
(en)
|
1983-11-02 |
1990-05-08 |
Integrated Genetics, Inc. |
Fsh
|
US5156957A
(en)
|
1983-11-02 |
1992-10-20 |
Genzyme Corporation |
Follicle stimulating hormone
|
US5639639A
(en)
|
1983-11-02 |
1997-06-17 |
Genzyme Corporation |
Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
|
US4703008A
(en)
|
1983-12-13 |
1987-10-27 |
Kiren-Amgen, Inc. |
DNA sequences encoding erythropoietin
|
US4496689A
(en)
*
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
EP0154316B1
(en)
|
1984-03-06 |
1989-09-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified lymphokine and production thereof
|
US4565653A
(en)
*
|
1984-03-30 |
1986-01-21 |
Pfizer Inc. |
Acyltripeptide immunostimulants
|
US4879236A
(en)
|
1984-05-16 |
1989-11-07 |
The Texas A&M University System |
Method for producing a recombinant baculovirus expression vector
|
US4931373A
(en)
|
1984-05-25 |
1990-06-05 |
Zymogenetics, Inc. |
Stable DNA constructs for expression of α-1 antitrypsin
|
US4589402A
(en)
|
1984-07-26 |
1986-05-20 |
Serono Laboratories, Inc. |
Method of in vitro fertilization
|
DE3584198D1
(de)
|
1984-08-01 |
1991-10-31 |
Boehringer Ingelheim Int |
Neue genetische sequenzen, die durch sie codierten interferon-peptide vom typ i und diese sie produzierende organismen.
|
US4761371A
(en)
|
1985-02-12 |
1988-08-02 |
Genentech, Inc. |
Insulin receptor
|
US4675414A
(en)
|
1985-03-08 |
1987-06-23 |
The United States Of America As Represented By The Secretary Of The Navy |
Maleimidomethyl-carbonate polyethers
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
GR860984B
(en)
|
1985-04-17 |
1986-08-18 |
Zymogenetics Inc |
Expression of factor vii and ix activities in mammalian cells
|
DE3684546D1
(de)
|
1985-04-22 |
1992-04-30 |
Genetics Inst |
Herstellung mit hoher leistung des aktivfaktors ix.
|
DE3676670D1
(de)
|
1985-06-26 |
1991-02-07 |
Cetus Corp |
Solubilisierung von proteinen fuer pharmazeutische zusammensetzungen mittels polymerkonjugierung.
|
US5206344A
(en)
|
1985-06-26 |
1993-04-27 |
Cetus Oncology Corporation |
Interleukin-2 muteins and polymer conjugation thereof
|
JPS6238172A
(ja)
|
1985-08-12 |
1987-02-19 |
株式会社 高研 |
抗血栓性医用材料の製造方法
|
US4810643A
(en)
|
1985-08-23 |
1989-03-07 |
Kirin- Amgen Inc. |
Production of pluripotent granulocyte colony-stimulating factor
|
US6004548A
(en)
|
1985-08-23 |
1999-12-21 |
Amgen, Inc. |
Analogs of pluripotent granulocyte colony-stimulating factor
|
IL80529A0
(en)
|
1985-11-14 |
1987-02-27 |
Daiichi Seiyaku Co |
Method of producing peptides
|
SE451849B
(sv)
|
1985-12-11 |
1987-11-02 |
Svenska Sockerfabriks Ab |
Sett att syntetisera glykosidiska bindningar samt anvendning av pa detta sett erhallna produkter
|
US4935349A
(en)
|
1986-01-17 |
1990-06-19 |
Zymogenetics, Inc. |
Expression of higher eucaryotic genes in aspergillus
|
IT1213029B
(it)
|
1986-01-30 |
1989-12-07 |
Bracco Ind Chimica Spa |
Chelati di ioni metallici paramagnetici.
|
US4767702A
(en)
|
1986-02-06 |
1988-08-30 |
Cohenford Menashi A |
Paper strip assay for neisseria species
|
AU597574B2
(en)
|
1986-03-07 |
1990-06-07 |
Massachusetts Institute Of Technology |
Method for enhancing glycoprotein stability
|
US5272066A
(en)
|
1986-03-07 |
1993-12-21 |
Massachusetts Institute Of Technology |
Synthetic method for enhancing glycoprotein stability
|
US4925796A
(en)
*
|
1986-03-07 |
1990-05-15 |
Massachusetts Institute Of Technology |
Method for enhancing glycoprotein stability
|
DE3607835A1
(de)
|
1986-03-10 |
1987-09-24 |
Boehringer Ingelheim Int |
Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
|
IT1203758B
(it)
|
1986-03-27 |
1989-02-23 |
Univ Roma |
Vettori di clonazione e di espressione di geni eterologhi in lieviti e lieviti trasformati con tali vettori
|
GB8610600D0
(en)
|
1986-04-30 |
1986-06-04 |
Novo Industri As |
Transformation of trichoderma
|
DK173067B1
(da)
|
1986-06-27 |
1999-12-13 |
Univ Washington |
Humant erythropoietin-gen, fremgangsmåde til ekspression deraf i transficerede cellelinier, de transficerede cellelinier sa
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
DE3633323A1
(de)
|
1986-10-01 |
1988-04-07 |
Boehringer Ingelheim Int |
Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
US4894330A
(en)
|
1986-12-23 |
1990-01-16 |
Cetus Corporation |
Purification of recombinant beta-interferon incorporating RP-HPLC
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
JP2795850B2
(ja)
|
1987-03-23 |
1998-09-10 |
ザイモジェネティクス,インコーポレイティド |
酵母発現ベクター
|
IL82834A
(en)
|
1987-06-09 |
1990-11-05 |
Yissum Res Dev Co |
Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom
|
EP0301670B2
(en)
|
1987-07-28 |
2000-06-14 |
Gist-Brocades N.V. |
Kluyveromyces as a host strain
|
US4897268A
(en)
|
1987-08-03 |
1990-01-30 |
Southern Research Institute |
Drug delivery system and method of making the same
|
US5252726A
(en)
|
1987-09-04 |
1993-10-12 |
Novo Nordisk A/S |
Promoters for use in aspergillus
|
GB8725529D0
(en)
|
1987-10-30 |
1987-12-02 |
Delta Biotechnology Ltd |
Polypeptides
|
US4847325A
(en)
|
1988-01-20 |
1989-07-11 |
Cetus Corporation |
Conjugation of polymer to colony stimulating factor-1
|
US5153265A
(en)
*
|
1988-01-20 |
1992-10-06 |
Cetus Corporation |
Conjugation of polymer to colony stimulating factor-1
|
GB8810808D0
(en)
|
1988-05-06 |
1988-06-08 |
Wellcome Found |
Vectors
|
JP2511494B2
(ja)
|
1988-05-12 |
1996-06-26 |
善治 松浦 |
日本脳炎ウイルス表面抗原蛋白質の製造法
|
FR2631974B1
(fr)
|
1988-05-31 |
1992-12-11 |
Agronomique Inst Nat Rech |
Baculovirus modifie, son procede de preparation et son application en tant que vecteur d'expression de genes
|
FR2649991B2
(fr)
|
1988-08-05 |
1994-03-04 |
Rhone Poulenc Sante |
Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
|
US5169933A
(en)
*
|
1988-08-15 |
1992-12-08 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
US5874261A
(en)
|
1988-09-02 |
1999-02-23 |
The Trustees Of The University Of Pennsylvania |
Method for the purification of glycosyltransferases
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
US5162215A
(en)
|
1988-09-22 |
1992-11-10 |
Amgen Inc. |
Method of gene transfer into chickens and other avian species
|
US5218092A
(en)
|
1988-09-29 |
1993-06-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
|
FR2638643B1
(fr)
|
1988-11-09 |
1991-04-12 |
Transgene Sa |
Sequence d'adn codant pour le facteur ix humain ou une proteine analogue, vecteur d'expression, cellules transformees, procede de preparation du facteur ix et produits obtenus correspondants
|
US5104651A
(en)
|
1988-12-16 |
1992-04-14 |
Amgen Inc. |
Stabilized hydrophobic protein formulations of g-csf
|
US5047335A
(en)
|
1988-12-21 |
1991-09-10 |
The Regents Of The University Of Calif. |
Process for controlling intracellular glycosylation of proteins
|
CA2006596C
(en)
|
1988-12-22 |
2000-09-05 |
Rika Ishikawa |
Chemically-modified g-csf
|
US6166183A
(en)
|
1992-11-30 |
2000-12-26 |
Kirin-Amgen, Inc. |
Chemically-modified G-CSF
|
WO1990007572A1
(en)
|
1988-12-23 |
1990-07-12 |
Genentech, Inc. |
HUMAN DNase
|
US5162228A
(en)
|
1988-12-28 |
1992-11-10 |
Takeda Chemical Industries, Ltd. |
Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
|
US5096815A
(en)
|
1989-01-06 |
1992-03-17 |
Protein Engineering Corporation |
Generation and selection of novel dna-binding proteins and polypeptides
|
US5198346A
(en)
|
1989-01-06 |
1993-03-30 |
Protein Engineering Corp. |
Generation and selection of novel DNA-binding proteins and polypeptides
|
JPH04502762A
(ja)
|
1989-01-19 |
1992-05-21 |
ジ・アップジョン・カンパニー |
ソマトトロピン・アナログ
|
AU620673B2
(en)
|
1989-01-31 |
1992-02-20 |
Pharmacia & Upjohn Company |
Somatotropin analogs
|
US4957773A
(en)
|
1989-02-13 |
1990-09-18 |
Syracuse University |
Deposition of boron-containing films from decaborane
|
US5338835A
(en)
|
1989-02-21 |
1994-08-16 |
Washington University |
CTP-extended form of FSH
|
US5475090A
(en)
|
1989-02-21 |
1995-12-12 |
Boyce Thompson Institute For Plant Research |
Gene coded for a polypeptide which enhances virus infection of host insects
|
US5194376A
(en)
|
1989-02-28 |
1993-03-16 |
University Of Ottawa |
Baculovirus expression system capable of producing foreign gene proteins at high levels
|
DE3906540A1
(de)
|
1989-03-02 |
1990-09-13 |
Behringwerke Ag |
Expressionsvektoren zur synthese von proteinen in der spalthefe schizosaccharomyces pombe
|
US5179023A
(en)
|
1989-03-24 |
1993-01-12 |
Research Corporation Technologies, Inc. |
Recombinant α-galactosidase a therapy for Fabry disease
|
US5059535A
(en)
|
1989-04-12 |
1991-10-22 |
Chembiomed, Ltd. |
Process for the separation and purification of sialyl transferases
|
DE69034200T2
(de)
|
1989-04-19 |
2006-05-24 |
Enzon, Inc. |
Verfahren zum Herstellen von modifizierten Polypeptiden die eine Polypeptid und ein Polyalkylenoxid enthalten
|
US5324844A
(en)
|
1989-04-19 |
1994-06-28 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
US5122614A
(en)
|
1989-04-19 |
1992-06-16 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
US5166322A
(en)
|
1989-04-21 |
1992-11-24 |
Genetics Institute |
Cysteine added variants of interleukin-3 and chemical modifications thereof
|
DE394538T1
(de)
|
1989-04-28 |
1991-04-11 |
Rhein Biotech Ges. Fuer Biotechnologische Prozesse Und Produkte Mbh, 4000 Duesseldorf |
Hefezellen der schwanniomyces-gattung.
|
US5766883A
(en)
|
1989-04-29 |
1998-06-16 |
Delta Biotechnology Limited |
Polypeptides
|
US5244805A
(en)
|
1989-05-17 |
1993-09-14 |
University Of Georgia Research Foundation, Inc. |
Baculovirus expression vectors
|
US5342940A
(en)
|
1989-05-27 |
1994-08-30 |
Sumitomo Pharmaceuticals Company, Limited |
Polyethylene glycol derivatives, process for preparing the same
|
FR2649565B1
(fr)
|
1989-07-05 |
1996-06-14 |
Lem |
Dispositif de couplage acoustique destine a effectuer des mesures et/ou des controles telephonometriques sur des combines telephoniques
|
US5077214A
(en)
|
1989-07-07 |
1991-12-31 |
The Texas A&M University System |
Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells
|
US5162222A
(en)
|
1989-07-07 |
1992-11-10 |
Guarino Linda A |
Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses
|
US5179007A
(en)
|
1989-07-07 |
1993-01-12 |
The Texas A & M University System |
Method and vector for the purification of foreign proteins
|
DE3924746A1
(de)
|
1989-07-26 |
1991-01-31 |
Behringwerke Ag |
Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper
|
FR2650598B1
(fr)
|
1989-08-03 |
1994-06-03 |
Rhone Poulenc Sante |
Derives de l'albumine a fonction therapeutique
|
US5155037A
(en)
|
1989-08-04 |
1992-10-13 |
The Texas A&M University System |
Insect signal sequences useful to improve the efficiency of processing and secretion of foreign genes in insect systems
|
US5023328A
(en)
|
1989-08-04 |
1991-06-11 |
The Texas A&M University System |
Lepidopteran AKH signal sequence
|
US5527527A
(en)
|
1989-09-07 |
1996-06-18 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
|
US5977307A
(en)
|
1989-09-07 |
1999-11-02 |
Alkermes, Inc. |
Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
|
US5672683A
(en)
|
1989-09-07 |
1997-09-30 |
Alkermes, Inc. |
Transferrin neuropharmaceutical agent fusion protein
|
US5182107A
(en)
|
1989-09-07 |
1993-01-26 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates
|
US5154924A
(en)
|
1989-09-07 |
1992-10-13 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
|
US5032519A
(en)
|
1989-10-24 |
1991-07-16 |
The Regents Of The Univ. Of California |
Method for producing secretable glycosyltransferases and other Golgi processing enzymes
|
US5580560A
(en)
|
1989-11-13 |
1996-12-03 |
Novo Nordisk A/S |
Modified factor VII/VIIa
|
US5312808A
(en)
|
1989-11-22 |
1994-05-17 |
Enzon, Inc. |
Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
|
IL96477A0
(en)
|
1989-12-01 |
1991-08-16 |
Amgen Inc |
Megakaryocyte production
|
US5104654A
(en)
*
|
1989-12-05 |
1992-04-14 |
University Of California |
Ovipositional disruption of the navel orangeworm with fatty acids
|
SE465222C5
(sv)
|
1989-12-15 |
1998-02-10 |
Pharmacia & Upjohn Ab |
Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
|
US5595900A
(en)
|
1990-02-14 |
1997-01-21 |
The Regents Of The University Of Michigan |
Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
|
US5324663A
(en)
|
1990-02-14 |
1994-06-28 |
The Regents Of The University Of Michigan |
Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
|
DE4009630C2
(de)
|
1990-03-26 |
1995-09-28 |
Reinhard Prof Dr Dr Brossmer |
CMP-aktivierte fluoreszierende Sialinsäuren sowie Verfahren zu ihrer Herstellung
|
US5606031A
(en)
|
1990-04-06 |
1997-02-25 |
Lile; Jack |
Production and purification of biologically active recombinant neurotrophic protein in bacteria
|
US5583042A
(en)
|
1990-04-16 |
1996-12-10 |
Neose Pharmaceuticals, Inc. |
Apparatus for the synthesis of saccharide compositions
|
US5180674A
(en)
|
1990-04-16 |
1993-01-19 |
The Trustees Of The University Of Pennsylvania |
Saccharide compositions, methods and apparatus for their synthesis
|
GB9107846D0
(en)
|
1990-04-30 |
1991-05-29 |
Ici Plc |
Polypeptides
|
US5951972A
(en)
*
|
1990-05-04 |
1999-09-14 |
American Cyanamid Company |
Stabilization of somatotropins and other proteins by modification of cysteine residues
|
US5399345A
(en)
|
1990-05-08 |
1995-03-21 |
Boehringer Mannheim, Gmbh |
Muteins of the granulocyte colony stimulating factor
|
US5219564A
(en)
|
1990-07-06 |
1993-06-15 |
Enzon, Inc. |
Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
|
CU22302A1
(es)
|
1990-09-07 |
1995-01-31 |
Cigb |
Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales
|
PL297610A1
(zh)
|
1990-07-10 |
1992-07-13 |
Boehringer Sohn Ingelheim |
|
FR2664905B1
(fr)
|
1990-07-18 |
1994-08-12 |
Agronomique Inst Nat Rech |
Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus.
|
DE4028800A1
(de)
|
1990-09-11 |
1992-03-12 |
Behringwerke Ag |
Gentechnische sialylierung von glykoproteinen
|
US5169784A
(en)
|
1990-09-17 |
1992-12-08 |
The Texas A & M University System |
Baculovirus dual promoter expression vector
|
US5529914A
(en)
|
1990-10-15 |
1996-06-25 |
The Board Of Regents The Univeristy Of Texas System |
Gels for encapsulation of biological materials
|
US5410016A
(en)
|
1990-10-15 |
1995-04-25 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
GB9023111D0
(en)
|
1990-10-24 |
1990-12-05 |
Wellcome Found |
Expression system
|
US5401650A
(en)
|
1990-10-24 |
1995-03-28 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Cloning and expression of biologically active α-galactosidase A
|
WO1992008790A1
(en)
|
1990-11-14 |
1992-05-29 |
Cargill, Incorporated |
Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins
|
US5164374A
(en)
|
1990-12-17 |
1992-11-17 |
Monsanto Company |
Use of oligosaccharides for treatment of arthritis
|
US5420027A
(en)
|
1991-01-10 |
1995-05-30 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the expression of biologically active fusion proteins comprising a eukaryotic cytochrome P450 fused to a reductase in bacteria
|
US6288304B1
(en)
|
1991-02-22 |
2001-09-11 |
Sembiosys Genetics Inc. |
Expression of somatotropin in plant seeds
|
US5948682A
(en)
|
1991-02-22 |
1999-09-07 |
Sembiosys Genetics Inc. |
Preparation of heterologous proteins on oil bodies
|
US5650554A
(en)
|
1991-02-22 |
1997-07-22 |
Sembiosys Genetics Inc. |
Oil-body proteins as carriers of high-value peptides in plants
|
US5788965A
(en)
|
1991-02-28 |
1998-08-04 |
Novo Nordisk A/S |
Modified factor VII
|
US5817788A
(en)
|
1991-02-28 |
1998-10-06 |
Zymogenetics, Inc. |
Modified factor VII
|
CA2103546C
(en)
|
1991-02-28 |
2002-10-01 |
Kathleen L. Berkner |
Modified factor vii
|
US5997864A
(en)
|
1995-06-07 |
1999-12-07 |
Novo Nordisk A/S |
Modified factor VII
|
US5861374A
(en)
|
1991-02-28 |
1999-01-19 |
Novo Nordisk A/S |
Modified Factor VII
|
US5833982A
(en)
|
1991-02-28 |
1998-11-10 |
Zymogenetics, Inc. |
Modified factor VII
|
WO1992016555A1
(en)
|
1991-03-18 |
1992-10-01 |
Enzon, Inc. |
Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers
|
US5278299A
(en)
|
1991-03-18 |
1994-01-11 |
Scripps Clinic And Research Foundation |
Method and composition for synthesizing sialylated glycosyl compounds
|
EP0576592B1
(en)
|
1991-03-18 |
2000-05-31 |
The Scripps Research Institute |
Oligosaccharide enzyme substrates and inhibitors: methods and compositions
|
US5212075A
(en)
|
1991-04-15 |
1993-05-18 |
The Regents Of The University Of California |
Compositions and methods for introducing effectors to pathogens and cells
|
DE69231467T2
(de)
|
1991-05-10 |
2001-01-25 |
Genentech, Inc. |
Auswählen von agonisten und antagonisten von liganden
|
SE9201544L
(sv)
|
1991-05-31 |
1992-12-01 |
Ciba Geigy Ag |
Saett att framstaella glykosyltransferaser
|
GB2256197B
(en)
|
1991-05-31 |
1995-11-22 |
Ciba Geigy Ag |
Yeast as host for expression of heterologous glycosyl transferase enzymes
|
US5472858A
(en)
|
1991-06-04 |
1995-12-05 |
Wisconsin Alumni Research Foundation |
Production of recombinant proteins in insect larvae
|
US5374655A
(en)
|
1991-06-10 |
1994-12-20 |
Alberta Research Council |
Methods for the synthesis of monofucosylated oligosaccharides terminating in di-N-acetyllactosaminyl structures
|
US5352670A
(en)
|
1991-06-10 |
1994-10-04 |
Alberta Research Council |
Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
|
SE9101853D0
(sv)
*
|
1991-06-17 |
1991-06-17 |
Jonas Wadstroem |
Improved tissue ashesive
|
KR950014915B1
(ko)
*
|
1991-06-19 |
1995-12-18 |
주식회사녹십자 |
탈시알로당단백-포함화합물
|
US5633146A
(en)
|
1991-07-02 |
1997-05-27 |
Rhone-Poulenc Rorer S.A. |
Method for producing recombinant proteins and host cells used therein
|
US5281698A
(en)
|
1991-07-23 |
1994-01-25 |
Cetus Oncology Corporation |
Preparation of an activated polymer ester for protein conjugation
|
EP0863154A1
(en)
|
1991-10-12 |
1998-09-09 |
The Regents Of The University Of California |
Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods
|
US6319695B1
(en)
|
1991-10-15 |
2001-11-20 |
The Scripps Research Insitute |
Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose
|
AU665599B2
(en)
|
1991-11-08 |
1996-01-11 |
Hemosol Inc. |
Hemoglobins as drug delivery agents
|
US5384249A
(en)
|
1991-12-17 |
1995-01-24 |
Kyowa Hakko Kogyo Co., Ltd. |
α2→3 sialyltransferase
|
DK8892D0
(da)
|
1992-01-23 |
1992-01-23 |
Symbicom Ab |
Humant proteingen
|
IT1260468B
(it)
|
1992-01-29 |
1996-04-09 |
|
Metodo per mantenere l'attivita' di enzimi proteolitici modificati con polietilenglicole
|
US6039944A
(en)
|
1992-02-28 |
2000-03-21 |
Zymogenetics, Inc. |
Modified Factor VII
|
US5965106A
(en)
|
1992-03-04 |
1999-10-12 |
Perimmune Holdings, Inc. |
In vivo binding pair pretargeting
|
US5858751A
(en)
*
|
1992-03-09 |
1999-01-12 |
The Regents Of The University Of California |
Compositions and methods for producing sialyltransferases
|
ATE228565T1
(de)
|
1992-03-09 |
2002-12-15 |
Univ California |
Nukleinsäure, expressionsvektor und zusammensetzungen zur identifizierung und herstellung von rekombinanten sialyltransferasen
|
US5962294A
(en)
|
1992-03-09 |
1999-10-05 |
The Regents Of The University Of California |
Compositions and methods for the identification and synthesis of sialyltransferases
|
WO1993018787A1
(en)
|
1992-03-25 |
1993-09-30 |
New York University |
Trans-sialidase and methods of use and making thereof
|
KR100278456B1
(ko)
|
1992-04-02 |
2001-01-15 |
존흐휴알. |
조절 신호인 지방체 단백질 시스-요소
|
US6037452A
(en)
|
1992-04-10 |
2000-03-14 |
Alpha Therapeutic Corporation |
Poly(alkylene oxide)-Factor VIII or Factor IX conjugate
|
US5516657A
(en)
|
1992-05-11 |
1996-05-14 |
Cambridge Biotech Corporation |
Baculovirus vectors for expression of secretory and membrane-bound proteins
|
JPH0686684A
(ja)
|
1992-05-26 |
1994-03-29 |
Monsanto Co |
シアロ抱合体の合成
|
US5614184A
(en)
|
1992-07-28 |
1997-03-25 |
New England Deaconess Hospital |
Recombinant human erythropoietin mutants and therapeutic methods employing them
|
EP0664710A4
(en)
|
1992-08-07 |
1998-09-30 |
Progenics Pharm Inc |
CD4-GAMMA2 AND CD4-IgG2 NON-PEPTIDYL CONJUGATE IMMUNOCONJUGATES AND USES THEREOF.
|
AU5006993A
(en)
|
1992-08-21 |
1994-03-15 |
Enzon, Inc. |
Novel attachment of polyalkylene oxides to bio-effecting substances
|
JP3979678B2
(ja)
|
1992-08-24 |
2007-09-19 |
サントリー株式会社 |
新規糖転移酵素及びそれをコードする遺伝子並びに該酵素の製造方法
|
WO1994005332A2
(en)
|
1992-09-01 |
1994-03-17 |
Berlex Laboratories, Inc. |
Glycolation of glycosylated macromolecules
|
US5348886A
(en)
|
1992-09-04 |
1994-09-20 |
Monsanto Company |
Method of producing recombinant eukaryotic viruses in bacteria
|
US5308460A
(en)
|
1992-10-30 |
1994-05-03 |
Glyko, Incorporated |
Rapid synthesis and analysis of carbohydrates
|
US6361977B1
(en)
|
1992-11-24 |
2002-03-26 |
S. Christopher Bauer |
Methods of using multivariant IL-3 hematopoiesis fusion protein
|
CA2148929A1
(en)
|
1992-11-27 |
1994-06-09 |
Eric G. Berger |
Proteins having glycosyltransferase activity
|
NZ250375A
(en)
|
1992-12-09 |
1995-07-26 |
Ortho Pharma Corp |
Peg hydrazone and peg oxime linkage forming reagents and protein derivatives
|
NO934477L
(no)
|
1992-12-09 |
1994-06-10 |
Ortho Pharma Corp |
PEG hydrazon- og PEG oksim-bindingdannende reagenser og proteinderivater derav
|
CA2110543A1
(en)
|
1992-12-09 |
1994-06-10 |
David E. Wright |
Peg hydrazone and peg oxime linkage forming reagents and protein derivatives thereof
|
WO1994015625A1
(en)
|
1993-01-15 |
1994-07-21 |
Enzon, Inc. |
Factor viii - polymeric conjugates
|
US5349001A
(en)
|
1993-01-19 |
1994-09-20 |
Enzon, Inc. |
Cyclic imide thione activated polyalkylene oxides
|
US5321095A
(en)
|
1993-02-02 |
1994-06-14 |
Enzon, Inc. |
Azlactone activated polyalkylene oxides
|
US5202413A
(en)
|
1993-02-16 |
1993-04-13 |
E. I. Du Pont De Nemours And Company |
Alternating (ABA)N polylactide block copolymers
|
US6180134B1
(en)
|
1993-03-23 |
2001-01-30 |
Sequus Pharmaceuticals, Inc. |
Enhanced ciruclation effector composition and method
|
EP0643132B1
(en)
|
1993-03-29 |
2006-05-31 |
Kyowa Hakko Kogyo Co., Ltd. |
Alpha-1,3-fucosyltransferase
|
CZ286046B6
(cs)
|
1993-04-29 |
1999-12-15 |
Abbott Laboratories |
Přípravky na bázi analogů erythropoietinu a způsoby jejich přípravy a farmaceutické přípravky s jejich obsahem
|
US5374541A
(en)
|
1993-05-04 |
1994-12-20 |
The Scripps Research Institute |
Combined use of β-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides
|
US5409817A
(en)
|
1993-05-04 |
1995-04-25 |
Cytel, Inc. |
Use of trans-sialidase and sialyltransferase for synthesis of sialylα2→3βgalactosides
|
US6174530B1
(en)
|
1993-05-05 |
2001-01-16 |
Gryphon Sciences |
Homogeneous polyoxime compositions and their preparation by parallel assembly
|
US6001364A
(en)
|
1993-05-05 |
1999-12-14 |
Gryphon Sciences |
Hetero-polyoxime compounds and their preparation by parallel assembly
|
WO1994026760A1
(en)
|
1993-05-14 |
1994-11-24 |
Cytel Corporation |
SIALYL Lex ANALOGUES AS INHIBITORS OF CELLULAR ADHESION
|
AU6663294A
(en)
*
|
1993-05-14 |
1994-12-12 |
Upjohn Company, The |
Cloned dna encoding a udp-galnac:polypeptide,n-acetylgalactos aminyltransferase
|
CA2162726A1
(en)
|
1993-05-21 |
1994-12-08 |
Kathleen L. Berkner |
Modified factor vii
|
WO1994028024A1
(en)
|
1993-06-01 |
1994-12-08 |
Enzon, Inc. |
Carbohydrate-modified polymer conjugates with erythropoietic activity
|
US5621039A
(en)
*
|
1993-06-08 |
1997-04-15 |
Hallahan; Terrence W. |
Factor IX- polymeric conjugates
|
JPH09503905A
(ja)
|
1993-07-15 |
1997-04-22 |
ネオゼ ファーマシューティカルス |
糖組成物の合成方法
|
DE4325317C2
(de)
|
1993-07-29 |
1998-05-20 |
Univ Dresden Tech |
Verfahren zur radioaktiven Markierung von Immunglobulinen
|
ZA946122B
(en)
|
1993-08-17 |
1995-03-20 |
Amgen Inc |
Erythropoietin analogs
|
JPH0770195A
(ja)
|
1993-08-23 |
1995-03-14 |
Yutaka Mizushima |
糖修飾インターフェロン
|
US6485930B1
(en)
|
1993-09-15 |
2002-11-26 |
The Scripps Research Institute |
Mannosyl transfer with regeneration of GDP-mannose
|
WO1995008573A1
(fr)
|
1993-09-22 |
1995-03-30 |
Ajinomoto Co., Inc. |
Peptide a action inhibant l'agregation plaquettaire et procede de production de ce compose
|
US5874075A
(en)
|
1993-10-06 |
1999-02-23 |
Amgen Inc. |
Stable protein: phospholipid compositions and methods
|
US5919455A
(en)
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
US5446090A
(en)
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
US5443953A
(en)
*
|
1993-12-08 |
1995-08-22 |
Immunomedics, Inc. |
Preparation and use of immunoconjugates
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
AU1377395A
(en)
|
1993-12-23 |
1995-07-10 |
University Technologies International Inc. |
Methods of expressing proteins in insect cells and methods of killing insects
|
US5369017A
(en)
*
|
1994-02-04 |
1994-11-29 |
The Scripps Research Institute |
Process for solid phase glycopeptide synthesis
|
JP3516272B2
(ja)
|
1994-02-10 |
2004-04-05 |
株式会社成和化成 |
化粧品基材
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
US6117679A
(en)
|
1994-02-17 |
2000-09-12 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US6165793A
(en)
|
1996-03-25 |
2000-12-26 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US5837458A
(en)
|
1994-02-17 |
1998-11-17 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
US5834252A
(en)
|
1995-04-18 |
1998-11-10 |
Glaxo Group Limited |
End-complementary polymerase reaction
|
US5492841A
(en)
*
|
1994-02-18 |
1996-02-20 |
E. I. Du Pont De Nemours And Company |
Quaternary ammonium immunogenic conjugates and immunoassay reagents
|
ES2104518T1
(es)
|
1994-03-07 |
1997-10-16 |
Dow Chemical Co |
Conjugados dendrimeros bioactivos y/o directores hacia diana.
|
US5545723A
(en)
|
1994-03-15 |
1996-08-13 |
Biogen Inc. |
Muteins of IFN-β
|
JP3090586B2
(ja)
|
1994-03-15 |
2000-09-25 |
片倉工業株式会社 |
システインプロテアーゼ遺伝子欠損バキュロウイルスおよびその製造法並びにこれを利用する有用タンパク質の製造法
|
IL113010A0
(en)
|
1994-03-31 |
1995-10-31 |
Pharmacia Ab |
Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
|
US5432059A
(en)
|
1994-04-01 |
1995-07-11 |
Specialty Laboratories, Inc. |
Assay for glycosylation deficiency disorders
|
US5646113A
(en)
*
|
1994-04-07 |
1997-07-08 |
Genentech, Inc. |
Treatment of partial growth hormone insensitivity syndrome
|
GB9408717D0
(en)
|
1994-05-03 |
1994-06-22 |
Biotech & Biolog Scien Res |
DNA sequences
|
US5629384A
(en)
*
|
1994-05-17 |
1997-05-13 |
Consiglio Nazionale Delle Ricerche |
Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces
|
JP3729210B2
(ja)
*
|
1994-07-26 |
2005-12-21 |
富士通株式会社 |
半導体装置の製造方法
|
US5871986A
(en)
|
1994-09-23 |
1999-02-16 |
The General Hospital Corporation |
Use of a baculovirus to express and exogenous gene in a mammalian cell
|
US5545553A
(en)
*
|
1994-09-26 |
1996-08-13 |
The Rockefeller University |
Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
|
EP0785276A4
(en)
|
1994-09-29 |
2002-01-09 |
Ajinomoto Kk |
MODIFICATION OF A PEPTIDE AND A PROTEIN
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
US5521299A
(en)
|
1994-11-22 |
1996-05-28 |
National Science Council |
Oligonucleotides for detection of baculovirus infection
|
US5834251A
(en)
*
|
1994-12-30 |
1998-11-10 |
Alko Group Ltd. |
Methods of modifying carbohydrate moieties
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
IL116730A0
(en)
|
1995-01-13 |
1996-05-14 |
Amgen Inc |
Chemically modified interferon
|
US5843705A
(en)
|
1995-02-21 |
1998-12-01 |
Genzyme Transgenic Corporation |
Transgenically produced antithrombin III
|
GB9506249D0
(en)
|
1995-03-27 |
1995-05-17 |
Karobio Ab |
Media for insect cell cultures
|
SE9501285L
(sv)
|
1995-04-06 |
1996-10-07 |
Johanna Ljung |
Förfarande för framställning av biologiskt aktiva proteiner
|
US5876980A
(en)
|
1995-04-11 |
1999-03-02 |
Cytel Corporation |
Enzymatic synthesis of oligosaccharides
|
DE69623005T2
(de)
|
1995-04-11 |
2003-04-03 |
Neose Technologies, Inc. |
Verbesserte verfahren zur enzymatischen synthese von oligosacchariden
|
US5922577A
(en)
|
1995-04-11 |
1999-07-13 |
Cytel Corporation |
Enzymatic synthesis of glycosidic linkages
|
US5728554A
(en)
|
1995-04-11 |
1998-03-17 |
Cytel Corporation |
Enzymatic synthesis of glycosidic linkages
|
US6030815A
(en)
|
1995-04-11 |
2000-02-29 |
Neose Technologies, Inc. |
Enzymatic synthesis of oligosaccharides
|
US5695760A
(en)
|
1995-04-24 |
1997-12-09 |
Boehringer Inglehiem Pharmaceuticals, Inc. |
Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation
|
EP0833663A4
(en)
|
1995-05-15 |
1999-04-07 |
Constantin A Bona |
CARBOHYDRATE MEDIATED COUPLING OF PEPTIDES TO IMMUNOGLOBULINES
|
US6015555A
(en)
|
1995-05-19 |
2000-01-18 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates
|
US5824864A
(en)
|
1995-05-25 |
1998-10-20 |
Pioneer Hi-Bred International, Inc. |
Maize gene and protein for insect control
|
US6127153A
(en)
|
1995-06-07 |
2000-10-03 |
Neose Technologies, Inc. |
Method of transferring at least two saccharide units with a polyglycosyltransferase, a polyglycosyltransferase and gene encoding a polyglycosyltransferase
|
WO1996040731A1
(en)
|
1995-06-07 |
1996-12-19 |
Mount Sinai School Of Medicine Of The City University Of New York |
Pegylated modified proteins
|
US5858752A
(en)
|
1995-06-07 |
1999-01-12 |
The General Hospital Corporation |
Fucosyltransferase genes and uses thereof
|
US6251864B1
(en)
|
1995-06-07 |
2001-06-26 |
Glaxo Group Limited |
Peptides and compounds that bind to a receptor
|
US5672662A
(en)
|
1995-07-07 |
1997-09-30 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
|
BR9610142A
(pt)
|
1995-07-27 |
1999-02-02 |
Cytec Tech Corp |
Processo de fabricação de papel e emulsão de encolamento alcalina para aperfeiçoar a eficiência de encolamento na fabricação de papel
|
US5770420A
(en)
|
1995-09-08 |
1998-06-23 |
The Regents Of The University Of Michigan |
Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
|
US5811634A
(en)
|
1995-09-12 |
1998-09-22 |
Thomas G. O'Brien |
Transgenic mammal encoding ornithine decarboxylase
|
CA2230492C
(en)
*
|
1995-09-21 |
2009-05-26 |
Genentech, Inc. |
Human growth hormone variants
|
SE9503380D0
(sv)
|
1995-09-29 |
1995-09-29 |
Pharmacia Ab |
Protein derivatives
|
US5767379A
(en)
|
1995-11-06 |
1998-06-16 |
John Howard |
Commercial production of avidin in plants
|
AU1158297A
(en)
|
1995-11-09 |
1997-05-29 |
Zymogenetics Inc. |
Production of gad65 in methylotrophic yeast
|
US6361974B1
(en)
|
1995-12-07 |
2002-03-26 |
Diversa Corporation |
Exonuclease-mediated nucleic acid reassembly in directed evolution
|
US5965408A
(en)
|
1996-07-09 |
1999-10-12 |
Diversa Corporation |
Method of DNA reassembly by interrupting synthesis
|
US6171820B1
(en)
|
1995-12-07 |
2001-01-09 |
Diversa Corporation |
Saturation mutagenesis in directed evolution
|
CA2165041C
(en)
|
1995-12-12 |
2005-07-05 |
The University Of British Columbia |
Methods and compositions for synthesis of oligosaccharides, and the products formed thereby
|
US5716812A
(en)
*
|
1995-12-12 |
1998-02-10 |
The University Of British Columbia |
Methods and compositions for synthesis of oligosaccharides, and the products formed thereby
|
WO1997021822A2
(en)
|
1995-12-12 |
1997-06-19 |
The University Of British Columbia |
Methods and compositions for synthesis of oligosaccharides using mutant glycosidase enzymes
|
JP3065925B2
(ja)
|
1996-01-30 |
2000-07-17 |
日清製油株式会社 |
活性酸素種消去剤及び退色防止剤
|
US5728580A
(en)
|
1996-02-20 |
1998-03-17 |
Cornell Research Foundation, Inc. |
Methods and culture media for inducing single cell suspension in insect cell lines
|
JP2000507095A
(ja)
*
|
1996-03-08 |
2000-06-13 |
ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン |
ネズミα(1,3)フコシルトランスフェラーゼFuc―TVII、それをコードするDNA、その製造法、それを認識する抗体、それを検出するためのイムノアッセイ、このようなDNAを含むプラスミド、およびこのようなプラスミドを含む細胞
|
US6096548A
(en)
|
1996-03-25 |
2000-08-01 |
Maxygen, Inc. |
Method for directing evolution of a virus
|
US5750383A
(en)
|
1996-05-14 |
1998-05-12 |
Boyce Thompson Institute For Plant Research, Inc. |
Baculovirus cloning system
|
US6096529A
(en)
|
1996-06-10 |
2000-08-01 |
National Research Council Of Canada |
Recombinant α-2,3-sialyltransferases and their uses
|
CA2261151C
(en)
|
1996-07-17 |
2003-09-16 |
Zymogenetics, Inc. |
Transformation of pichia methanolica
|
CN1238806A
(zh)
|
1996-07-17 |
1999-12-15 |
津莫吉尼蒂克斯公司 |
甲醇毕赤酵母营养突变体的制备
|
JP4410852B2
(ja)
|
1996-08-02 |
2010-02-03 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
単一の共有結合n末端水溶性ポリマーを有するポリペプチド
|
EP0953354A4
(en)
|
1996-08-13 |
2002-10-23 |
Fujisawa Pharmaceutical Co |
HEMATOPOIETIC STEM CELLS PROLIFERING ACTIVE SUBSTANCES
|
US20020064546A1
(en)
|
1996-09-13 |
2002-05-30 |
J. Milton Harris |
Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
|
AU735695B2
(en)
|
1996-10-10 |
2001-07-12 |
Neose Technologies, Inc. |
Carbohydrate purification using ultrafiltration, reverse osmosis and nanofiltration
|
CA2276267C
(en)
*
|
1996-10-15 |
2009-12-22 |
The Liposome Company, Inc. |
Peptide-lipid conjugates, liposomes and liposomal drug delivery
|
NZ335628A
(en)
|
1996-11-08 |
2000-10-27 |
Neose Technologies Inc |
Improved expression vectors comprising a nucleic acid construct with tac and gal bacterial promoters
|
US5856452A
(en)
|
1996-12-16 |
1999-01-05 |
Sembiosys Genetics Inc. |
Oil bodies and associated proteins as affinity matrices
|
BR9606270A
(pt)
|
1996-12-18 |
1998-09-22 |
Univ Minas Gerais |
Processo para a produção da proteína do interferon beta-cis humano recombinante e proteína de interferon beta-cis humano recombinante
|
ATE263841T1
(de)
|
1997-01-16 |
2004-04-15 |
Neose Technologies Inc |
Praktische in vitro sialylierung von rekombinanten glykpproteinen
|
JP2001508783A
(ja)
|
1997-01-29 |
2001-07-03 |
ポリマスク・ファーマシューティカルズ・パブリック・リミテッド・カンパニー |
Peg化法
|
DE19709787A1
(de)
|
1997-03-11 |
1998-09-17 |
Bayer Ag |
Oligosaccaride und deren Derivate sowie ein chemo-enzymatisches Verfahren zu deren Herstellung
|
US5945314A
(en)
*
|
1997-03-31 |
1999-08-31 |
Abbott Laboratories |
Process for synthesizing oligosaccharides
|
WO1998049198A1
(en)
|
1997-04-30 |
1998-11-05 |
Enzon, Inc. |
Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
|
JPH10307356A
(ja)
|
1997-05-08 |
1998-11-17 |
Konica Corp |
ハロゲン化銀乳剤およびそれを用いたハロゲン化銀写真感光材料
|
US6183738B1
(en)
*
|
1997-05-12 |
2001-02-06 |
Phoenix Pharamacologics, Inc. |
Modified arginine deiminase
|
US6075134A
(en)
|
1997-05-15 |
2000-06-13 |
The Regents Of The University Of California |
Glycoconjugates and methods
|
US7585645B2
(en)
|
1997-05-27 |
2009-09-08 |
Sembiosys Genetics Inc. |
Thioredoxin and thioredoxin reductase containing oil body based products
|
US6399337B1
(en)
|
1997-06-06 |
2002-06-04 |
The Governors Of The University Of Alberta |
α1,3-fucosyltransferase
|
ES2235336T3
(es)
|
1997-06-13 |
2005-07-01 |
Gryphon Therapeutics, Inc. |
Ligacion quimica nativa en fase solida de peptidos desprotegidos o protegidos en la cisteina n-terminal en solucion acuosa.
|
US6210736B1
(en)
|
1997-06-17 |
2001-04-03 |
Genzyme Transgenics Corporation |
Transgenically produced prolactin
|
DE69830315T2
(de)
|
1997-06-24 |
2006-02-02 |
Genentech Inc., San Francisco |
Galactosylierte glykoproteine enthaltende zusammensetzungen und verfahren zur deren herstellung
|
WO1999000150A2
(en)
|
1997-06-27 |
1999-01-07 |
Regents Of The University Of California |
Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor
|
US6187564B1
(en)
|
1997-07-10 |
2001-02-13 |
Beth Israel Deaconess Medical Center |
DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics
|
US6090584A
(en)
|
1997-08-21 |
2000-07-18 |
University Technologies International Inc. |
Baculovirus artificial chromosomes and methods of use
|
US20030027257A1
(en)
*
|
1997-08-21 |
2003-02-06 |
University Technologies International, Inc. |
Sequences for improving the efficiency of secretion of non-secreted protein from mammalian and insect cells
|
WO1999013063A1
(en)
|
1997-09-09 |
1999-03-18 |
Nycomed Imaging As |
Factor vii fragments and analogs thereof and their use in the treatment of blood clottng disorders
|
ATE419009T1
(de)
|
1997-10-31 |
2009-01-15 |
Genentech Inc |
Methoden und zusammensetzungen bestehend aus glykoprotein-glykoformen
|
AU744303B2
(en)
|
1997-12-01 |
2002-02-21 |
Neose Technologies, Inc. |
Enzymatic synthesis of gangliosides
|
WO1999029835A1
(en)
|
1997-12-08 |
1999-06-17 |
Board Of Trustees Of The University Of Arkansas |
PURIFIED β1,2-XYLOSYLTRANSFERASE AND USES THEREOF
|
US7244601B2
(en)
|
1997-12-15 |
2007-07-17 |
National Research Council Of Canada |
Fusion proteins for use in enzymatic synthesis of oligosaccharides
|
EP0924298A1
(en)
*
|
1997-12-18 |
1999-06-23 |
Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) |
Protein expression in baculovirus vector expression systems
|
TW445295B
(en)
|
1997-12-31 |
2001-07-11 |
Shiu Li Wei |
Expression vector pcDNA3.1-HC for human erythropoietin, BHK-21 host cell line transformed therewith, and production of human erythropoietin using the transformed cell
|
CA2316834C
(en)
|
1998-01-07 |
2006-01-03 |
Shearwater Polymers, Inc. |
Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom
|
AU2559799A
(en)
|
1998-01-22 |
1999-08-09 |
Genentech Inc. |
Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies and uses of same
|
AR014491A1
(es)
|
1998-01-29 |
2001-02-28 |
Dow Agrosciences Llc |
Metodo para obtener plantas transgenicas fertiles de gossypium hirsutum.
|
WO1999045964A1
(en)
|
1998-03-12 |
1999-09-16 |
Shearwater Polymers, Incorporated |
Poly(ethylene glycol) derivatives with proximal reactive groups
|
US6689604B1
(en)
|
1998-03-20 |
2004-02-10 |
National Research Council Of Canada |
Lipopolysaccharide α-2,3 sialyltransferase of Campylobacter jejuni and its uses
|
JP2002507577A
(ja)
*
|
1998-03-25 |
2002-03-12 |
スローン−ケッタリング インスティトュート フォア キャンサー リサーチ |
三量体抗原性o−結合複合糖ペプチド、その製造方法及びその使用
|
DK2180007T4
(da)
|
1998-04-20 |
2017-11-27 |
Roche Glycart Ag |
Glycosyleringsteknik for antistoffer til forbedring af antistofafhængig cellecytotoxicitet
|
EP1075282B1
(en)
|
1998-04-28 |
2005-06-15 |
Applied Research Systems ARS Holding N.V. |
Peg-lhrh analog conjugates
|
US20030166525A1
(en)
|
1998-07-23 |
2003-09-04 |
Hoffmann James Arthur |
FSH Formulation
|
US6245539B1
(en)
|
1998-10-06 |
2001-06-12 |
Board Of Trustees Operating Michigan State University |
Human asparaginyl-tRNA synthetase DNA
|
EA005682B1
(ru)
|
1998-10-06 |
2005-04-28 |
Марк Аарон Эмалфарб |
Трансформированные грибы, в частности рода chrysosporium, способные к синтезу гетерологичных полипептидов
|
LT2599503T
(lt)
|
1998-10-16 |
2017-06-26 |
Biogen Ma Inc. |
Interferono beta-1a polimero konjugatai ir jų panaudojimas
|
US7304150B1
(en)
|
1998-10-23 |
2007-12-04 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
ATE365210T1
(de)
|
1998-10-30 |
2007-07-15 |
Novozymes As |
Glykosylierte proteine mit reduzierter allergenität
|
ATE408006T1
(de)
|
1998-11-13 |
2008-09-15 |
Henrick Clausen |
Udp-galaktose: beta-i(n)-acetyl-glukosamin beta1, 3 galaktosyltransferasen, beta3gal-t5
|
DE19852729A1
(de)
|
1998-11-16 |
2000-05-18 |
Werner Reutter |
Rekombinante Glycoproteine, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und ihre Verwendung
|
EP1131415A4
(en)
|
1998-11-18 |
2002-09-11 |
Neose Technologies Inc |
PRODUCTION OF CHEAP OLIGOSACCHARIDES
|
US6465220B1
(en)
|
1998-12-21 |
2002-10-15 |
Glycozym Aps |
Glycosylation using GalNac-T4 transferase
|
EA004685B1
(ru)
|
1999-01-29 |
2004-06-24 |
Эмджен Инк. |
Конъюгаты гксф
|
US6503744B1
(en)
|
1999-02-01 |
2003-01-07 |
National Research Council Of Canada |
Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
|
US6699705B2
(en)
|
1999-02-01 |
2004-03-02 |
National Research Council Of Canada |
Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
|
US6949372B2
(en)
|
1999-03-02 |
2005-09-27 |
The Johns Hopkins University |
Engineering intracellular sialylation pathways
|
JP2002542792A
(ja)
|
1999-04-22 |
2002-12-17 |
アストラゼネカ アクチボラグ |
ホスホ−n−アセチルムラミル−ペンタペプチド転移酵素活性を検出するためのアッセイ
|
US6365410B1
(en)
|
1999-05-19 |
2002-04-02 |
Genencor International, Inc. |
Directed evolution of microorganisms
|
PE20010288A1
(es)
*
|
1999-07-02 |
2001-03-07 |
Hoffmann La Roche |
Derivados de eritropoyetina
|
US6261805B1
(en)
*
|
1999-07-15 |
2001-07-17 |
Boyce Thompson Institute For Plant Research, Inc. |
Sialyiation of N-linked glycoproteins in the baculovirus expression vector system
|
AU6357900A
(en)
|
1999-07-20 |
2001-02-05 |
Amgen, Inc. |
Hyaluronic acid-protein conjugates, pharmaceutical compositions and related methods
|
US6642038B1
(en)
|
1999-09-14 |
2003-11-04 |
Genzyme Glycobiology Research Institute, Inc. |
GlcNAc phosphotransferase of the lysosomal targeting pathway
|
US6716626B1
(en)
*
|
1999-11-18 |
2004-04-06 |
Chiron Corporation |
Human FGF-21 nucleic acids
|
AU1804201A
(en)
|
1999-12-02 |
2001-06-12 |
Zymogenetics Inc. |
Methods for targeting cells that express fibroblast growth receptor-3 or-2
|
US6348558B1
(en)
|
1999-12-10 |
2002-02-19 |
Shearwater Corporation |
Hydrolytically degradable polymers and hydrogels made therefrom
|
MXPA02006215A
(es)
|
1999-12-22 |
2003-10-15 |
Nektar Therapeutics Al Corp |
Metodo para preparar esteres de 1-benzotriazolil carbonato de poli(etilenglicol).
|
ATE522563T1
(de)
|
1999-12-24 |
2011-09-15 |
Kyowa Hakko Kirin Co Ltd |
Verzweigte polyalkylenglykole
|
AU2352201A
(en)
|
1999-12-30 |
2001-07-16 |
Maxygen Aps |
Improved lysosomal enzymes and lysosomal enzyme activators
|
JP2003519478A
(ja)
|
2000-01-10 |
2003-06-24 |
マキシゲン・ホールディングズ・リミテッド |
G−csf結合体
|
US6646110B2
(en)
|
2000-01-10 |
2003-11-11 |
Maxygen Holdings Ltd. |
G-CSF polypeptides and conjugates
|
US6555660B2
(en)
*
|
2000-01-10 |
2003-04-29 |
Maxygen Holdings Ltd. |
G-CSF conjugates
|
US6423488B1
(en)
|
2000-01-15 |
2002-07-23 |
Avigenics, Inc |
High throughput screening assay for detecting a DNA sequence
|
WO2001058493A1
(en)
|
2000-02-11 |
2001-08-16 |
Maxygen Aps |
Conjugates of follicle stimulating hormones
|
DE60138364D1
(de)
|
2000-02-11 |
2009-05-28 |
Bayer Healthcare Llc |
Gerinnungsfaktor vii oder viia konjugate
|
AU2001232337A1
(en)
|
2000-02-18 |
2001-08-27 |
Kanagawa Academy Of Science And Technology |
Pharmaceutical composition, reagent and method for intracerebral delivery of pharmaceutically active ingredient or labeling substance
|
US20010041683A1
(en)
|
2000-03-09 |
2001-11-15 |
Schmitz Harold H. |
Cocoa sphingolipids, cocoa extracts containing sphingolipids and methods of making and using same
|
AU2001281463A1
(en)
*
|
2000-03-16 |
2001-09-24 |
The Regents Of The University Of California |
Chemoselective ligation
|
US6586398B1
(en)
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
WO2001083725A1
(en)
|
2000-05-03 |
2001-11-08 |
Novo Nordisk A/S |
Human coagulation factor vii variants
|
US6905683B2
(en)
|
2000-05-03 |
2005-06-14 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII variants
|
US7338932B2
(en)
|
2000-05-11 |
2008-03-04 |
Glycozym Aps |
Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
|
AU2001263149A1
(en)
*
|
2000-05-12 |
2001-11-26 |
Neose Technologies, Inc. |
In vitro fucosylation recombinant glycopeptides
|
PT1311285E
(pt)
*
|
2000-05-15 |
2005-06-30 |
Hoffmann La Roche |
Composicao farmaceutica liquida contendo um derivado de eritropoietina
|
JP4873818B2
(ja)
|
2000-05-16 |
2012-02-08 |
ボルダー バイオテクノロジー, インコーポレイテッド |
遊離システイン残基を含有するタンパク質をリフォールディングする方法
|
EP2322644A1
(en)
*
|
2000-06-28 |
2011-05-18 |
GlycoFi, Inc. |
Methods for producing modified glycoproteins
|
EP1299535A2
(en)
|
2000-06-30 |
2003-04-09 |
Maxygen Aps |
Peptide extended glycosylated polypeptides
|
US6423826B1
(en)
|
2000-06-30 |
2002-07-23 |
Regents Of The University Of Minnesota |
High molecular weight derivatives of vitamin K-dependent polypeptides
|
US20020064835A1
(en)
|
2000-07-10 |
2002-05-30 |
Diosynth Rtp, Inc. |
Purification of human troponin I
|
KR100396983B1
(ko)
|
2000-07-29 |
2003-09-02 |
이강춘 |
고반응성의 가지 달린 고분자 유도체 및 고분자와 단백질또는 펩타이드의 접합체
|
WO2002013843A2
(en)
|
2000-08-17 |
2002-02-21 |
University Of British Columbia |
Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours
|
WO2002013873A2
(en)
|
2000-08-17 |
2002-02-21 |
Synapse Technologies, Inc. |
P97-active agent conjugates and their methods of use
|
HUP0301245A3
(en)
|
2000-10-02 |
2005-12-28 |
Novo Nordisk Healthcare Ag |
Tmethod for the production of vitamin k-dependent proteins
|
US20020142964A1
(en)
|
2000-11-02 |
2002-10-03 |
Nissen Torben Lauesgaard |
Single-chain polypeptides
|
DK1337549T3
(da)
|
2000-11-27 |
2006-07-31 |
Lonza Ag |
Fremgangsmåde til foldning af kemisk syntetiserede polypeptider
|
US20030165849A1
(en)
|
2000-11-28 |
2003-09-04 |
Biliang Zhang |
Methods and reagents for introducing a sulfhydryl group into the 5'-terminus of RNA
|
WO2002049673A2
(en)
*
|
2000-12-20 |
2002-06-27 |
F. Hoffmann-La Roche Ag |
Conjugates of erythropoietin (pep) with polyethylene glycol (peg)
|
BR0116381A
(pt)
|
2000-12-20 |
2004-02-25 |
Hoffmann La Roche |
Conjugado, composição farmacêutica que compreende o mesmo e sua utilização, processo para o tratamento profilático e/ou terapêutico de distúrbios, processo para a preparação de um conjugado, compostos e glicoproteìnas de eritropoetina
|
US7892730B2
(en)
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
US6531121B2
(en)
*
|
2000-12-29 |
2003-03-11 |
The Kenneth S. Warren Institute, Inc. |
Protection and enhancement of erythropoietin-responsive cells, tissues and organs
|
PA8536201A1
(es)
|
2000-12-29 |
2002-08-29 |
Kenneth S Warren Inst Inc |
Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
|
SE0004932D0
(sv)
|
2000-12-31 |
2000-12-31 |
Apbiotech Ab |
A method for mixed mode adsorption and mixed mode adsorbents
|
MXPA03007619A
(es)
|
2001-02-27 |
2003-12-04 |
Maxygen Aps |
Nuevas moleculas similares a interferon beta.
|
CA2441580A1
(en)
|
2001-03-22 |
2002-10-03 |
Novo Nordisk Health Care Ag |
Coagulation factor vii derivatives
|
US7235638B2
(en)
|
2001-03-22 |
2007-06-26 |
Novo Nordisk Healthcare A/G |
Coagulation factor VII derivatives
|
DE60239454D1
(de)
|
2001-05-03 |
2011-04-28 |
Merck Patent Gmbh |
Rekombinanter, tumorspezifischer antikörper und dessen verwendung
|
EP1392350A2
(en)
*
|
2001-05-11 |
2004-03-03 |
Aradigm Corporation |
Optimization of the molecular properties and formulation of proteins delivered by inhalation
|
WO2002092619A2
(en)
|
2001-05-14 |
2002-11-21 |
The Gouvernment Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Modified growth hormone
|
CA2452582C
(en)
|
2001-07-11 |
2013-01-22 |
Maxygen Holdings, Ltd. |
G-csf conjugates
|
KR100453877B1
(ko)
|
2001-07-26 |
2004-10-20 |
메덱스젠 주식회사 |
연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 TNFR/Fc 융합 단백질, 상기 단백질을 코딩하는 DNA, 상기 DNA를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
|
WO2003011879A1
(en)
|
2001-08-01 |
2003-02-13 |
Neose Technologies, Inc. |
Neutral glycosphingolipids and glycosyl-sphingosines and methods for isolating the same
|
JP2005527467A
(ja)
|
2001-08-29 |
2005-09-15 |
ネオーズ テクノロジーズ, インコーポレイテッド |
新規な合成ガングリオシド誘導体およびその組成物
|
US6930086B2
(en)
|
2001-09-25 |
2005-08-16 |
Hoffmann-La Roche Inc. |
Diglycosylated erythropoietin
|
US7052868B2
(en)
|
2001-09-27 |
2006-05-30 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII polypeptides
|
SG159381A1
(en)
*
|
2001-10-10 |
2010-03-30 |
Novo Nordisk As |
Remodeling and glycoconjugation of peptides
|
US7226903B2
(en)
|
2001-10-10 |
2007-06-05 |
Neose Technologies, Inc. |
Interferon beta: remodeling and glycoconjugation of interferon beta
|
US7265085B2
(en)
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycoconjugation methods and proteins/peptides produced by the methods
|
US7399613B2
(en)
*
|
2001-10-10 |
2008-07-15 |
Neose Technologies, Inc. |
Sialic acid nucleotide sugars
|
US8008252B2
(en)
*
|
2001-10-10 |
2011-08-30 |
Novo Nordisk A/S |
Factor VII: remodeling and glycoconjugation of Factor VII
|
US7125843B2
(en)
*
|
2001-10-19 |
2006-10-24 |
Neose Technologies, Inc. |
Glycoconjugates including more than one peptide
|
US7157277B2
(en)
*
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
US7439043B2
(en)
|
2001-10-10 |
2008-10-21 |
Neose Technologies, Inc. |
Galactosyl nucleotide sugars
|
US7265084B2
(en)
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
US7214660B2
(en)
*
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7179617B2
(en)
|
2001-10-10 |
2007-02-20 |
Neose Technologies, Inc. |
Factor IX: remolding and glycoconjugation of Factor IX
|
US7795210B2
(en)
*
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
US7297511B2
(en)
*
|
2001-10-10 |
2007-11-20 |
Neose Technologies, Inc. |
Interferon alpha: remodeling and glycoconjugation of interferon alpha
|
US7173003B2
(en)
*
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
US7696163B2
(en)
*
|
2001-10-10 |
2010-04-13 |
Novo Nordisk A/S |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US6784154B2
(en)
|
2001-11-01 |
2004-08-31 |
University Of Utah Research Foundation |
Method of use of erythropoietin to treat ischemic acute renal failure
|
US7368108B2
(en)
*
|
2001-11-28 |
2008-05-06 |
Neose Technologies, Inc. |
Glycopeptide remodeling using amidases
|
WO2003046150A2
(en)
|
2001-11-28 |
2003-06-05 |
Neose Technologies, Inc. |
Glycoprotein remodeling using endoglycanases
|
US7473680B2
(en)
*
|
2001-11-28 |
2009-01-06 |
Neose Technologies, Inc. |
Remodeling and glycoconjugation of peptides
|
US20060035224A1
(en)
*
|
2002-03-21 |
2006-02-16 |
Johansen Jack T |
Purification methods for oligonucleotides and their analogs
|
US6786755B2
(en)
|
2002-03-27 |
2004-09-07 |
Molex Incorporated |
Differential signal connector assembly with improved retention capabilities
|
US7569376B2
(en)
|
2002-05-03 |
2009-08-04 |
Neose Technologies, Inc. |
Fucosyltransferase fusion protein
|
WO2004000366A1
(en)
|
2002-06-21 |
2003-12-31 |
Novo Nordisk Health Care Ag |
Pegylated factor vii glycoforms
|
MXPA04012496A
(es)
|
2002-06-21 |
2005-09-12 |
Novo Nordisk Healthcare Ag |
Glicoformos del factor vii pegilados.
|
DE10232916B4
(de)
|
2002-07-19 |
2008-08-07 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vorrichtung und Verfahren zum Charakterisieren eines Informationssignals
|
WO2004009838A2
(en)
|
2002-07-23 |
2004-01-29 |
Neose Technologies, Inc. |
H. Pylori FUCOSYLTRANSFERASES
|
BR0312896A
(pt)
|
2002-08-01 |
2005-06-14 |
Ca Nat Research Council |
Glicanos e glicopeptìdeos de campylobacter
|
EP2255826B1
(en)
|
2002-08-02 |
2016-04-13 |
GlaxoSmithKline Biologicals S.A. |
Neisserial vaccine compositions comprising a combination of antigens
|
EP1549332A4
(en)
*
|
2002-09-05 |
2008-06-18 |
Gen Hospital Corp |
MODIFIED ASIALO-INTERFERONS AND USES THEREOF
|
CA2497794A1
(en)
|
2002-09-06 |
2004-03-18 |
Bayer Pharmaceuticals Corporation |
Modified glp-1 receptor agonists and their pharmacological methods of use
|
WO2005025606A1
(en)
|
2003-09-09 |
2005-03-24 |
Warren Pharmaceuticals, Inc. |
Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
|
CN1703421B
(zh)
|
2002-09-20 |
2010-06-23 |
法玛西亚公司 |
降低peg化蛋白的聚集体水平的方法
|
WO2004029090A1
(en)
|
2002-09-25 |
2004-04-08 |
Novo Nordisk Health Care Ag |
Human coagulation factor vii polypeptides
|
US20040062748A1
(en)
|
2002-09-30 |
2004-04-01 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
EP1549677B1
(en)
|
2002-09-30 |
2011-04-13 |
Bayer HealthCare LLC |
FVII OR FVIIa VARIANTS HAVING INCREASED CLOTTING ACTIVITY
|
NZ539415A
(en)
|
2002-10-09 |
2008-12-24 |
Neose Technologies Inc |
Remodelling and glycoconjugation of erythropoietin
|
AU2003275952A1
(en)
*
|
2002-11-08 |
2004-06-07 |
Glycozym Aps |
Inactivated ga1 - nac - transferases, methods for inhibitors of such transferases and their use
|
JP4412461B2
(ja)
|
2002-11-20 |
2010-02-10 |
日油株式会社 |
修飾された生体関連物質、その製造方法および中間体
|
US7459436B2
(en)
|
2002-11-22 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
US20050064540A1
(en)
*
|
2002-11-27 |
2005-03-24 |
Defrees Shawn Ph.D |
Glycoprotein remodeling using endoglycanases
|
EP1424344A1
(en)
|
2002-11-29 |
2004-06-02 |
Aventis Behring Gesellschaft mit beschränkter Haftung |
Modified cDNA factor VIII and its derivates
|
EP1428878B1
(en)
|
2002-12-13 |
2008-08-20 |
Bioceuticals Arzneimittel AG |
Process for the production and purification of erythropoietin
|
EA008866B1
(ru)
|
2002-12-26 |
2007-08-31 |
Маунтин Вью Фамэсьютикэлс, Инк. |
ПОЛИМЕРНЫЙ КОНЪЮГАТ МОДИФИКАЦИЙ ИНТЕРФЕРОНА-β, ФАРМАЦЕВТИЧЕСКИЕ ПРОДУКТЫ НА ЕГО ОСНОВЕ И СПОСОБ ИХ ПОЛУЧЕНИЯ
|
US7041635B2
(en)
|
2003-01-28 |
2006-05-09 |
In2Gen Co., Ltd. |
Factor VIII polypeptide
|
ES2911435T3
(es)
|
2003-02-26 |
2022-05-19 |
Nektar Therapeutics |
Conjugados de polímero-resto de Factor VIII
|
CA2519092C
(en)
|
2003-03-14 |
2014-08-05 |
Neose Technologies, Inc. |
Branched water-soluble polymers and their conjugates
|
US20060276618A1
(en)
|
2003-03-18 |
2006-12-07 |
Defrees Shawn |
Activated forms of water-soluble polymers
|
SI1605897T1
(sl)
|
2003-03-19 |
2012-11-30 |
Lilly Co Eli |
Polietilen glikol povezane GLP spojine
|
WO2006127896A2
(en)
|
2005-05-25 |
2006-11-30 |
Neose Technologies, Inc. |
Glycopegylated factor ix
|
EP1615945B1
(en)
|
2003-04-09 |
2011-09-28 |
BioGeneriX AG |
Glycopegylation methods and proteins/peptides produced by the methods
|
WO2004091499A2
(en)
|
2003-04-09 |
2004-10-28 |
Neose Technologies, Inc. |
Intracellular formation of peptide conjugates
|
US7718363B2
(en)
|
2003-04-25 |
2010-05-18 |
The Kenneth S. Warren Institute, Inc. |
Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
|
EP1624891B2
(en)
|
2003-05-06 |
2013-04-10 |
Biogen Idec Hemophilia Inc. |
Clotting factor-fc chimeric proteins to treat hemophilia
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
ATE540055T1
(de)
|
2003-05-09 |
2012-01-15 |
Biogenerix Ag |
Zusammensetzungen und verfahren zur herstellung von glykosylierungsmutanten des menschlichen wachstumshormons
|
WO2004101597A2
(en)
|
2003-05-13 |
2004-11-25 |
Frutarom Ltd. |
Methods for the reduction of disulfide bonds
|
US7074755B2
(en)
|
2003-05-17 |
2006-07-11 |
Centocor, Inc. |
Erythropoietin conjugate compounds with extended half-lives
|
EP1481985A1
(en)
|
2003-05-28 |
2004-12-01 |
Innogenetics N.V. |
Modified hepatitis C virus (HCV) NS3 for medical treatment
|
GB0315457D0
(en)
|
2003-07-01 |
2003-08-06 |
Celltech R&D Ltd |
Biological products
|
US9005625B2
(en)
*
|
2003-07-25 |
2015-04-14 |
Novo Nordisk A/S |
Antibody toxin conjugates
|
JP4337457B2
(ja)
*
|
2003-07-30 |
2009-09-30 |
日本電気株式会社 |
アンテナ装置及びそれを用いた無線通信装置
|
EP1653996A2
(en)
|
2003-08-08 |
2006-05-10 |
Novo Nordisk Health Care AG |
Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
|
US20060198819A1
(en)
|
2003-08-08 |
2006-09-07 |
Novo Nordisk Healthcare A/G |
Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
|
WO2005014024A2
(en)
|
2003-08-08 |
2005-02-17 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of a polymer and a protein linked by an oxime linking group
|
US7524813B2
(en)
|
2003-10-10 |
2009-04-28 |
Novo Nordisk Health Care Ag |
Selectively conjugated peptides and methods of making the same
|
CA2547140A1
(en)
*
|
2003-11-24 |
2005-06-09 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
US8633157B2
(en)
*
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
EP1694351A2
(en)
|
2003-12-03 |
2006-08-30 |
Neose Technologies, Inc. |
Glycopegylated follicle stimulating hormone
|
US7956032B2
(en)
*
|
2003-12-03 |
2011-06-07 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
AU2004296860B2
(en)
|
2003-12-03 |
2010-04-22 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
NZ547554A
(en)
|
2003-12-03 |
2009-09-25 |
Biogenerix Ag |
Glycopegylated granulocyte colony stimulating factor
|
US20060040856A1
(en)
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
US20080318850A1
(en)
|
2003-12-03 |
2008-12-25 |
Neose Technologies, Inc. |
Glycopegylated Factor Ix
|
CN101072789B
(zh)
|
2004-01-08 |
2013-05-15 |
生物种属学股份公司 |
肽的o-连接的糖基化
|
WO2005067601A2
(en)
|
2004-01-09 |
2005-07-28 |
Neose Technologies, Inc. |
Vectors for recombinant protein expression in e.coli
|
US20070105770A1
(en)
|
2004-01-21 |
2007-05-10 |
Novo Nordisk A/S |
Transglutaminase mediated conjugation of peptides
|
EP1720892B1
(en)
|
2004-01-26 |
2013-07-24 |
BioGeneriX AG |
Branched polymer-modified sugars and nucleotides
|
EP3736335A1
(en)
|
2004-02-12 |
2020-11-11 |
Archemix LLC |
Aptamer therapeutics useful in the treatment of complement-related disorders
|
JP2007531715A
(ja)
|
2004-03-17 |
2007-11-08 |
イーライ リリー アンド カンパニー |
グリコール結合fgf−21化合物
|
EP1745141B2
(en)
|
2004-05-04 |
2019-09-25 |
Novo Nordisk Health Care AG |
O-linked glycoforms of faktor vii and method to manufacture them
|
US20070037966A1
(en)
|
2004-05-04 |
2007-02-15 |
Novo Nordisk A/S |
Hydrophobic interaction chromatography purification of factor VII polypeptides
|
JP4251399B2
(ja)
|
2004-05-21 |
2009-04-08 |
独立行政法人産業技術総合研究所 |
O結合型糖鎖が付加されたペプチドのスクリーニング方法
|
JP2008512085A
(ja)
|
2004-06-03 |
2008-04-24 |
ネオス テクノロジーズ インコーポレイティッド |
切断型GalNAcT2ポリペプチドおよび核酸
|
WO2005121332A2
(en)
|
2004-06-03 |
2005-12-22 |
Neose Technologies, Inc. |
Truncated st6galnaci polypeptides and nucleic acids
|
JP2008509889A
(ja)
|
2004-06-30 |
2008-04-03 |
イージェン コーポレーション |
ペグ化インターフェロンα−1b
|
KR101100059B1
(ko)
|
2004-06-30 |
2011-12-29 |
넥타르 테라퓨틱스 |
중합체인자 ix 부분의 접합체
|
WO2006014466A2
(en)
|
2004-07-02 |
2006-02-09 |
The Kenneth S. Warren Institute, Inc. |
Novel carbamylated epo and method for its production
|
WO2006014349A2
(en)
|
2004-07-02 |
2006-02-09 |
The Kenneth S. Warren Institute, Inc. |
Method of producing fully carbamylated erythropoietin
|
US20080300173A1
(en)
|
2004-07-13 |
2008-12-04 |
Defrees Shawn |
Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
|
US20090292110A1
(en)
|
2004-07-23 |
2009-11-26 |
Defrees Shawn |
Enzymatic modification of glycopeptides
|
SE0401951D0
(sv)
|
2004-07-29 |
2004-07-29 |
Amersham Biosciences Ab |
Chromatography method
|
US20060024286A1
(en)
*
|
2004-08-02 |
2006-02-02 |
Paul Glidden |
Variants of tRNA synthetase fragments and uses thereof
|
US20090176967A1
(en)
|
2004-08-02 |
2009-07-09 |
Novo Nordisk Healthcare A/G |
Conjugation of FVII
|
BRPI0514396A2
(pt)
|
2004-08-17 |
2009-05-12 |
Csl Behring Gmbh |
polipeptìdeos dependentes de vitamina k modificada
|
WO2006031811A2
(en)
|
2004-09-10 |
2006-03-23 |
Neose Technologies, Inc. |
Glycopegylated interferon alpha
|
WO2006035057A1
(en)
|
2004-09-29 |
2006-04-06 |
Novo Nordisk Health Care Ag |
Modified proteins
|
HUE026826T2
(en)
|
2004-10-29 |
2016-07-28 |
Ratiopharm Gmbh |
Modeling and glycopegylation of fibroblast growth factor (FGF)
|
KR101654011B1
(ko)
|
2004-11-12 |
2016-09-05 |
바이엘 헬스케어 엘엘씨 |
Fviii의 부위 지향 변형
|
US20090054623A1
(en)
*
|
2004-12-17 |
2009-02-26 |
Neose Technologies, Inc. |
Lipo-Conjugation of Peptides
|
WO2006073846A2
(en)
|
2004-12-22 |
2006-07-13 |
Ambrx, Inc. |
Methods for expression and purification of recombinant human growth hormone
|
JP2008526864A
(ja)
*
|
2005-01-06 |
2008-07-24 |
ネオス テクノロジーズ インコーポレイテッド |
糖断片を用いる糖結合
|
ES2449195T3
(es)
|
2005-01-10 |
2014-03-18 |
Ratiopharm Gmbh |
Factor estimulante de colonias de granulocitos glicopegilado
|
WO2006078645A2
(en)
|
2005-01-19 |
2006-07-27 |
Neose Technologies, Inc. |
Heterologous polypeptide expression using low multiplicity of infection of viruses
|
PA8660701A1
(es)
|
2005-02-04 |
2006-09-22 |
Pfizer Prod Inc |
Agonistas de pyy y sus usos
|
WO2006102652A2
(en)
|
2005-03-24 |
2006-09-28 |
Neose Technologies, Inc. |
Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
|
EP1866427A4
(en)
|
2005-03-30 |
2010-09-01 |
Novo Nordisk As |
MANUFACTURING PROCESS FOR THE PRODUCTION OF CULTIVE PEPTIDES IN CELL LINES OF INSECTS
|
EP1871801A2
(en)
|
2005-04-01 |
2008-01-02 |
Novo Nordisk Health Care AG |
Blood coagulation fviii analogues
|
WO2006121569A2
(en)
|
2005-04-08 |
2006-11-16 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
AU2006245969B8
(en)
|
2005-05-11 |
2011-08-25 |
Eth Zurich |
Recombinant N-glycosylated proteins from procaryotic cells
|
US20110003744A1
(en)
|
2005-05-25 |
2011-01-06 |
Novo Nordisk A/S |
Glycopegylated Erythropoietin Formulations
|
EP1888098A2
(en)
|
2005-05-25 |
2008-02-20 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin formulations
|
EP1893632B1
(en)
|
2005-06-17 |
2015-08-12 |
Novo Nordisk Health Care AG |
Selective reduction and derivatization of engineered factor vii proteins comprising at least one non-native cysteine
|
US20070105755A1
(en)
*
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
US20090305967A1
(en)
|
2005-08-19 |
2009-12-10 |
Novo Nordisk A/S |
Glycopegylated factor vii and factor viia
|
WO2007031559A2
(en)
*
|
2005-09-14 |
2007-03-22 |
Novo Nordisk Health Care Ag |
Human coagulation factor vii polypeptides
|
US20090048440A1
(en)
*
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
DE102006009437A1
(de)
|
2006-03-01 |
2007-09-13 |
Bioceuticals Arzneimittel Ag |
G-CSF-Flüssigformulierung
|
US7645860B2
(en)
|
2006-03-31 |
2010-01-12 |
Baxter Healthcare S.A. |
Factor VIII polymer conjugates
|
BRPI0712008A2
(pt)
|
2006-05-24 |
2012-01-10 |
Novo Nordisk Healthcare Ag |
derivados e análogos de fix prolongados
|
ES2516694T3
(es)
|
2006-07-21 |
2014-10-31 |
Ratiopharm Gmbh |
Glicosilación de péptidos a través de secuencias de glicosilación con unión en O
|
ITMI20061624A1
(it)
*
|
2006-08-11 |
2008-02-12 |
Bioker Srl |
Mono-coniugati sito-specifici di g-csf
|
JP5570809B2
(ja)
*
|
2006-09-01 |
2014-08-13 |
ノボ ノルディスク ヘルス ケア アーゲー |
修飾タンパク質
|
US8969532B2
(en)
|
2006-10-03 |
2015-03-03 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
|
KR101556248B1
(ko)
|
2006-10-04 |
2015-09-30 |
노보 노르디스크 에이/에스 |
글리세롤이 연결된 페길화된 당 및 글리코펩티드
|
US20080207487A1
(en)
|
2006-11-02 |
2008-08-28 |
Neose Technologies, Inc. |
Manufacturing process for the production of polypeptides expressed in insect cell-lines
|
PL2144923T3
(pl)
*
|
2007-04-03 |
2013-12-31 |
Biogenerix Ag |
Sposoby leczenia z użyciem glikopegilowanego G-CSF
|
US20090053167A1
(en)
*
|
2007-05-14 |
2009-02-26 |
Neose Technologies, Inc. |
C-, S- and N-glycosylation of peptides
|
US20110177029A1
(en)
|
2007-06-04 |
2011-07-21 |
Novo Nordisk A/S |
O-linked glycosylation using n-acetylglucosaminyl transferases
|
US9493499B2
(en)
|
2007-06-12 |
2016-11-15 |
Novo Nordisk A/S |
Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography
|
US8207112B2
(en)
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|
CN102037004A
(zh)
|
2008-01-08 |
2011-04-27 |
生物种属学股份公司 |
使用寡糖基转移酶的多肽的糖缀合
|